ISSN:
1546-1696
Source:
Nature Archives 1869 - 2009
Topics:
Biology
,
Process Engineering, Biotechnology, Nutrition Technology
Notes:
[Auszug] Commercial activity in the RNA interference (RNAi) space continues apace, even with key challenges related to interpretation of the technology, a wall of regulatory issues and several intellectual property (IP) contests remaining. In early September, Alnylam Pharmaceuticals, of Cambridge, ...
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1038/nbt1107-1191
Permalink